Anderson J P, Fischer A B, Johnson M A. "一种帕唑帕尼杂质13的合成方法" [P]. US Patent, US 11718117 B2, 2023-07-04.
发明人林芳,郑宇鹏,杨光. "Method for the Synthesis of Pazopanib Impurity 13" [P]. 中国发明专利, 专利号 CN 117052584 B, 授权公告日 2017-10-13.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of 帕唑帕尼杂质13 in Pharmaceutical Formulations". Food Chem., 2010, 797, 1797-1816.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of 帕唑帕尼杂质13 as an Impurity". Rapid Commun. Mass Spectrom., 2018, 405, (6), 7052-7080.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of Pazopanib Impurity 13 Using HRMS and NMR". Chromatographia, 2017, 822, 2159-2175.
Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate 帕唑帕尼杂质13 Profile in Drug Substances According to ICH Guidelines". Sci. Total Environ., 2011, 1177, 8795-8808.